Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Luber, PA

Joe Luber, Quakertown, PA US

Patent application numberDescriptionPublished
20090060983Method And Composition For Making An Orally Disintegrating Dosage Form - The present invention relates to a process for making orally disintegrating dosage forms and means for packaging such dosage forms.03-05-2009
20100021507Method and Composition for Making an Orally Disintegrating Dosage Form - The present invention relates to a process for making orally disintegrating dosage forms and means for packaging such dosage forms.01-28-2010

Joseph Luber, Quakertown, PA US

Patent application numberDescriptionPublished
20090004248DUAL PORTION DOSAGE LOZENGE FORM - The present invention relates to a dosage form including both a disintegrative tablet portion and a hard candy portion, wherein: (i) the disintegrative tablet portion comprises at least one pharmaceutically active agent, and (ii) the hard candy portion covers at least 20% of the surface of the disintegrative tablet portion, and wherein the disintegration time of the hard candy portion is at least ten times longer than the disintegration time of the disintegrative tablet portion.01-01-2009
20090110716ORALLY DISINTEGRATIVE DOSAGE FORM - The present invention features an orally disintegrating dosage form including from about 5% to about 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the at least hydrated salt has a dehydration temperature of from about 20 to about 120° C.04-30-2009
20100016348ORALLY DISINTEGRATIVE DOSAGE FORM - The present invention features an orally disintegrating dosage form including from about 5% to about 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the at least hydrated salt has a dehydration temperature of from about 20 to about 120° C.01-21-2010
20100016451Orally Disintegrative Dosage Form - The present invention features an orally disintegrating dosage form including from about 5% to about 40%, by weight, of at least one hydrated salt and a pharmaceutically active agent, wherein the at least hydrated salt has a dehydration temperature of from about 20 to about 120° C.01-21-2010
20100124560MULTI PORTION INTRA-ORAL DOSAGE FORM AND USE THEREOF - The present invention relates to a multi portion intra-oral dosage form where at least one portion is rapidly disintegrating and at least one portion is slowly disintegrating, whereby the disintegration time for the slowest disintegrating portion is at least two times longer than for the most rapidly disintegrating portion. Of certain interest is use of sensory markers/signals as conceptual aids for the subject.05-20-2010
20100330169Pharmaceutical Tablet Containing A Liquid Filled Capsule - In one aspect, the present invention features a tablet including a compressed core and a liquid filled capsule, wherein the compressed core includes a first pharmaceutically active agent, the compressed core has a cavity exposed on the surface of the core, and the capsule is contained within the cavity such that a portion of the capsule is visible on the surface of the tablet, wherein the capsule has a diameter of at least 500 microns.12-30-2010
20110142931SOFT TABLET CONTAINING DEXTROSE MONOHYDRATE - The invention relates to a tablet capable of being chewed or disintegrated in the oral cavity, which comprises a pharmaceutically active ingredient, and a matrix comprising directly compressible dextrose monohydrate and sucralose, said tablet being substantially fat free and said matrix being substantially free of non-saccharide, water soluble polymeric binders.06-16-2011

Patent applications by Joseph Luber, Quakertown, PA US

Joseph Luber, Quaketown, PA US

Patent application numberDescriptionPublished
20090162435MANUFACTURE OF TABLET - The present invention features a method of manufacturing a tablet containing a pharmaceutically active agent by the steps of: (a) adding a powder containing a pharmaceutically-acceptable carrier to a die cavity; (b) injecting a liquid drug composition containing the pharmaceutically active agent into the die cavity such that the liquid drug composition contacts the powder; (c) compressing the combination of the powder and the liquid drug composition within the die cavity to form the tablet; and (d) removing the tablet from the die cavity.06-25-2009